MétaCan
Menu
← Back to cohort

S1676 Comparing Top-Down and Step-Up Strategies in the Treatment of IBD: An Updated Meta-Analysis of Remission and Surgical Outcomes

2025· article· en· W4417171144 on OpenAlexaboutno aff
Priya Kumari Maheshwari, Dheeraj Kumar Maheshwari, Mohammad Alhadj Ali, Ibrahim Reyaz, Omer Mohammed, Binay Panjiyar, Chanpreet Singh, Sheenam Garg, Arghadip Das, Sai Nikhitha Malapati, Saif Syed, Aasim Akthar Ahmed

Bibliographic record

VenueThe American Journal of Gastroenterology · 2025
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicInflammatory Bowel Disease
Canadian institutionsnot available
Fundersnot available
KeywordsObservational studyRandomized controlled trialOdds ratioUlcerative colitisConfidence intervalMeta-analysisInflammatory bowel diseaseStudy heterogeneityInclusion and exclusion criteria

Abstract

fetched live from OpenAlex

Introduction: Inflammatory bowel disease (IBD), comprising crohn’s disease (CD) and ulcerative colitis (UC), is a chronic, progressive condition associated with cumulative bowel damage and frequent need for surgical intervention. Traditional step-up therapy delays advanced treatment until complications arise, whereas emerging evidence suggests that early initiation of biologics or immunomodulators may improve remission and reduce surgery risk. This has prompted interest in top-down strategies; however, pooled comparisons between top-down and step-up approaches remain limited. Methods: A comprehensive literature search was performed using PubMed and Google Scholar to identify relevant randomized controlled trials (RCTs) and observational studies reporting remission (clinical and endoscopic) and surgical outcomes. Study quality was assessed using the Cochrane Risk of Bias tool for RCTs and the Newcastle-Ottawa Scale for observational studies. Data was extracted independently, and pooled odds ratios (OR) with 95% confidence intervals (CI) were calculated using a random-effects model. Statistical heterogeneity was evaluated using the I² statistic. Results: A total of 7 studies met inclusion criteria, encompassing patients with both CD and UC. For remission, pooled data from 2692 patients receiving top-down therapy and 2214 receiving step-up therapy showed no significant difference between strategies (OR: 1.11; 95% CI: 0.46–2.67; I² = 97%; P = 0.81). In contrast, surgical outcomes favored top-down therapy, with pooled data from 7308 patients in the top-down group and 6451 in the step-up group demonstrating a significantly lower risk of surgical intervention (OR: 0.65; 95% CI: 0.48-0.88; I² = 61%; P = 0.005). Conclusion: In this meta-analysis, top-down therapy was associated with a significantly lower risk of surgical intervention compared to step-up therapy, suggesting a potential long-term benefit of early biologic initiation in IBD. However, no significant difference was observed in clinical remission rates between the 2 strategies. These findings underscore the need to individualize treatment decisions, considering both disease severity and patient-specific factors. The substantial heterogeneity underscores the need for further prospective, standardized studies to clarify the optimal sequencing of therapy in IBD management.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.019
metaresearch head score (Gemma)0.036
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Meta-analysis · Consensus signal: Meta-analysis
GenreCandidate signal: Empirical · Consensus signal: none
Teacher disagreement score0.020
Threshold uncertainty score0.102

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0190.036
Meta-epidemiology (narrow)0.0030.001
Meta-epidemiology (broad)0.0200.075
Bibliometrics0.0090.007
Science and technology studies0.0010.001
Scholarly communication0.0050.002
Open science0.0020.002
Research integrity0.0030.003
Insufficient payload (model declined to judge)0.0070.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.019
GPT teacher head0.304
Teacher spread0.286 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designMeta-analysis
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueThe American Journal of Gastroenterology→Same topicInflammatory Bowel Disease→French-language works237,207→